152 related articles for article (PubMed ID: 12777388)
1. Structural comparison of human monoamine oxidases A and B: mass spectrometry monitoring of cysteine reactivities.
Hubalek F; Pohl J; Edmondson DE
J Biol Chem; 2003 Aug; 278(31):28612-8. PubMed ID: 12777388
[TBL] [Abstract][Full Text] [Related]
2. Topological probes of monoamine oxidases A and B in rat liver mitochondria: inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis.
Wang J; Edmondson DE
Biochemistry; 2011 Apr; 50(13):2499-505. PubMed ID: 21341713
[TBL] [Abstract][Full Text] [Related]
3. Loss of serotonin oxidation as a component of the altered substrate specificity in the Y444F mutant of recombinant human liver MAO A.
Nandigama RK; Miller JR; Edmondson DE
Biochemistry; 2001 Dec; 40(49):14839-46. PubMed ID: 11732903
[TBL] [Abstract][Full Text] [Related]
4. High-level expression of human liver monoamine oxidase B in Pichia pastoris.
Newton-Vinson P; Hubalek F; Edmondson DE
Protein Expr Purif; 2000 Nov; 20(2):334-45. PubMed ID: 11049757
[TBL] [Abstract][Full Text] [Related]
5. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man.
Murphy DL; Lipper S; Slater S; Shiling D
Psychopharmacology (Berl); 1979 Apr; 62(2):129-32. PubMed ID: 111275
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of the active site of brain monoamine oxidase.
Youdim MB
Monogr Neural Sci; 1980; 7():176-92. PubMed ID: 6785574
[TBL] [Abstract][Full Text] [Related]
7. Inversion of selectivity of N-substituted propargylamine monoamine oxidase inhibitors following structural modifications to quaternary salts.
Yu PH; Davis BA
Int J Biochem Cell Biol; 1999 Dec; 31(12):1391-7. PubMed ID: 10641793
[TBL] [Abstract][Full Text] [Related]
8. Effects of carboxyl-terminal truncations on the activity and solubility of human monoamine oxidase B.
Rebrin I; Geha RM; Chen K; Shih JC
J Biol Chem; 2001 Aug; 276(31):29499-506. PubMed ID: 11371556
[TBL] [Abstract][Full Text] [Related]
9. Comparative membrane locations and activities of human monoamine oxidases expressed in yeast.
Urban P; Andersen JK; Hsu HP; Pompon D
FEBS Lett; 1991 Jul; 286(1-2):142-6. PubMed ID: 1864361
[TBL] [Abstract][Full Text] [Related]
10. Amine oxidases from Aspergillus niger: identification of a novel flavin-dependent enzyme.
Schilling B; Lerch K
Biochim Biophys Acta; 1995 Apr; 1243(3):529-37. PubMed ID: 7727530
[TBL] [Abstract][Full Text] [Related]
11. Identification of a region important for human monoamine oxidase B substrate and inhibitor selectivity.
Grimsby J; Zentner M; Shih JC
Life Sci; 1996; 58(9):777-87. PubMed ID: 8632725
[TBL] [Abstract][Full Text] [Related]
12. [Isolation and characterization of an evolutionary precursor of human monoamine oxidases A and B].
Singer TP; Iankovskaia VL; Bernard S; Cronin C; Sablin SO
Vopr Med Khim; 1997; 43(6):440-56. PubMed ID: 9503562
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Fisar Z; Hroudová J; Raboch J
Neuro Endocrinol Lett; 2010; 31(5):645-56. PubMed ID: 21200377
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of monoamine oxidase in zebrafish (Danio rerio).
Setini A; Pierucci F; Senatori O; Nicotra A
Comp Biochem Physiol B Biochem Mol Biol; 2005 Jan; 140(1):153-61. PubMed ID: 15621520
[TBL] [Abstract][Full Text] [Related]
15. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
[TBL] [Abstract][Full Text] [Related]
16. Problems with the measurement of monoamine oxidase A protein concentration in mitochondrial preparations. Revised molecular activities and implications for estimating ratios of MAO A:MAO B molecules from radiochemical assay data.
Riley LA; Denney RM
Biochem Pharmacol; 1991 Oct; 42(10):1953-9. PubMed ID: 1741773
[TBL] [Abstract][Full Text] [Related]
17. Structural and mechanistic studies of arylalkylhydrazine inhibition of human monoamine oxidases A and B.
Binda C; Wang J; Li M; Hubalek F; Mattevi A; Edmondson DE
Biochemistry; 2008 May; 47(20):5616-25. PubMed ID: 18426226
[TBL] [Abstract][Full Text] [Related]
18. Histamine N-methyltransferase: inhibition by monoamine oxidase inhibitors.
Boudíková-Girard B; Scott MC; Weinshilboum R
Agents Actions; 1993 Sep; 40(1-2):1-10. PubMed ID: 8147263
[TBL] [Abstract][Full Text] [Related]
19. Mutation of surface cysteine 374 to alanine in monoamine oxidase A alters substrate turnover and inactivation by cyclopropylamines.
Vintém AP; Price NT; Silverman RB; Ramsay RR
Bioorg Med Chem; 2005 May; 13(10):3487-95. PubMed ID: 15848762
[TBL] [Abstract][Full Text] [Related]
20. Isoelectric analysis of 3H-pargyline-labelled monoamine oxidase in rat and carp.
Obata T; Yamanaka Y; Sho S; Kinemuchi H
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1990; 96(1):91-8. PubMed ID: 1980888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
